MK-1403 Single Dose Formulation PK Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507984-20-00

Acronym

MK-1403-003

Enrollment

Registered

2023-11-06

Start date

2023-11-17

Completion date

2024-03-07

Last updated

2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026